ライフサイエンスコーパス: hydrops fetalis

1 oglobin [Hb] H disease) or lethal (Hb Bart's hydrops fetalis).

2 unexplained cases of severe neonatal NSHA or hydrops fetalis.

3 aplastic crisis, pure red cell aplasia, and hydrops fetalis.

4 ted ova, 9 stillbirths, 1 termination due to hydrops fetalis, 1 cleft palate, and 2 threatened aborti

5 al effusions (2 of 2), ascites (6 of 8), and hydrops fetalis (5 of 8).

6 ) Bart's disease is the most common cause of hydrops fetalis among Southeast Asians.

7 efects in the formation of the heart lead to hydrops fetalis and are likely the cause of embryonic le

8 /-) embryos die at midgestation with extreme hydrops fetalis and cardiovascular abnormalities, includ

9 The Calcrl-/- embryos exhibit extreme hydrops fetalis and cardiovascular defects, including th

10 m of GLD with a high incidence of non-immune hydrops fetalis and childhood onset of facial and four l

11 uding fifth disease, arthritis, myocarditis, hydrops fetalis, and aplastic crisis.

12 that is characterized by multiple anomalies, hydrops fetalis, and death within the first 8 wk of life

13 od cells, potentially causing severe anemia, hydrops fetalis, and fetal death.

14 pregnancies can be affected by fetal anemia, hydrops fetalis, and perinatal death.

15 linical and electrophysiologic predictors of hydrops fetalis; and 3) to describe the medium-term foll

16 haemoglobin H disease and haemoglobin Bart's hydrops fetalis, are an important public health concern

17 Early lethal hydrops fetalis, arthrogryposis, microcephaly, and polym

18 t with severe nonimmune hemolytic anemia and hydrops fetalis at birth.

19 a complicated by ventricular dysfunction and hydrops fetalis carries a significant risk of morbidity

20 The majority of hydrops fetalis cases are nonimmune conditions that pres

21 Hydrops fetalis describes fluid accumulation in at least

22 vious sibling born with hemolytic anemia and hydrops fetalis died on the second day of life.

23 of diverse pathological outcomes, including hydrops fetalis, fetal myocarditis, meningoencephalitis,

24 se control group or Group 4; n = 4); and (5) hydrops fetalis from non-Bart's causes (Group 5; n = 5).

25 lly relevant thalassemias (hemoglobin Bart's hydrops fetalis, hemoglobin H disease, beta-thalassemia

26 s in 8 group A versus 0 group B (P < 0.007), hydrops fetalis in 8 group A versus 0 group B (P < 0.007

27 absence of Adm may be one cause of nonimmune hydrops fetalis in humans.

28 BHFS is the most common cause of hydrops fetalis in Southeast Asia; however, owing to glo

29 re the correction of alpha-thalassemia major hydrops fetalis in transgene-free iPS cells using zinc f

30 erited form of lymphatic-related (nonimmune) hydrops fetalis (LRHF).

31 etuses with incessant tachycardia and either hydrops fetalis (n=24) or ventricular dysfunction (n=2)

32 Non-immune hydrops fetalis (NIHF) is a complex condition with a hig

33 Nonimmune hydrops fetalis (NIHF), a fetal abnormality that is ofte

34 cted fetuses and children included nonimmune hydrops fetalis (NIHF), pleural and pericardial effusion

35 CD2) gene in multiple fetuses with nonimmune hydrops fetalis (NIHF).

36 In utero infection may result in hydrops fetalis or congenital anemia.

37 icular tachycardia, even when accompanied by hydrops fetalis or ventricular dysfunction.

38 We report a case of hydrops fetalis secondary to cCMV infection with minimal

39 h homozygous mutants develop polyhydramnios, hydrops fetalis, spina bifida occulta and osteochondrody

40 Hemoglobin Bart's hydrops fetalis syndrome (BHFS) represents the most seve

41 Hemoglobin (Hb) Bart's hydrops fetalis syndrome (BHFS) resulting from alpha(0)-

42 nd neonatal deaths associated with nonimmune hydrops fetalis uncovered 2 heterozygous missense varian

43 oss of beta-glucuronidase activity can cause hydrops fetalis, with in utero or postnatal death of the